Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
ONCBeOne Medicines Ltd.
| Figure | ONCBeOne Medicines Ltd.FY2025 · Dec |
|---|---|
| Revenue | $5.34B |
| Revenue, yoy | +40.2% |
| Net income | $286.93M |
| Net income, yoy | +144.5% |
| Net margin | 5.4% |
| Free cash flow | $941.74M |
| FCF margin | 17.6% |
| EPS, diluted | $0.19 |
Add another company.
Annual · FY2021–FY2025 · USD
From SEC EDGARSame fiscal periods, as filed